Page last updated: 2024-10-29

imipramine and Granulomatous Disease, Chronic

imipramine has been researched along with Granulomatous Disease, Chronic in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Trush, MA1
Van Dyke, K1
Wilson, ME1
Reasor, MJ1

Other Studies

1 other study available for imipramine and Granulomatous Disease, Chronic

ArticleYear
Chemiluminescence resulting from an interaction between imipramine and human polymorphonuclear leukocytes.
    Research communications in chemical pathology and pharmacology, 1977, Volume: 18, Issue:4

    Topics: Amitriptyline; Animals; Cell-Free System; Child; Drug Synergism; Granulomatous Disease, Chronic; Hum

1977